TMC Life Sciences Bhd
KLSE:TMCLIFE
Intrinsic Value
TMC Life Sciences Bhd.operates as an investment holding company. [ Read More ]
The intrinsic value of one TMCLIFE stock under the Base Case scenario is 0.694 MYR. Compared to the current market price of 0.665 MYR, TMC Life Sciences Bhd is Undervalued by 4%.
Valuation Backtest
TMC Life Sciences Bhd
Run backtest to discover the historical profit from buying and selling TMCLIFE stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Balance Sheet Decomposition
TMC Life Sciences Bhd
Current Assets | 272.9m |
Cash & Short-Term Investments | 190.3m |
Receivables | 69.7m |
Other Current Assets | 12.8m |
Non-Current Assets | 918.4m |
Long-Term Investments | 2.1m |
PP&E | 711.3m |
Intangibles | 205m |
Current Liabilities | 97m |
Accounts Payable | 78.5m |
Other Current Liabilities | 18.5m |
Non-Current Liabilities | 217.3m |
Long-Term Debt | 195.9m |
Other Non-Current Liabilities | 21.4m |
Earnings Waterfall
TMC Life Sciences Bhd
Revenue
|
352.5m
MYR
|
Cost of Revenue
|
-100.5m
MYR
|
Gross Profit
|
252m
MYR
|
Operating Expenses
|
-182.2m
MYR
|
Operating Income
|
69.7m
MYR
|
Other Expenses
|
-12.5m
MYR
|
Net Income
|
57.2m
MYR
|
Free Cash Flow Analysis
TMC Life Sciences Bhd
MYR | |
Free Cash Flow | MYR |
TMCLIFE Profitability Score
Profitability Due Diligence
TMC Life Sciences Bhd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Score
TMC Life Sciences Bhd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
TMCLIFE Solvency Score
Solvency Due Diligence
TMC Life Sciences Bhd's solvency score is 65/100. The higher the solvency score, the more solvent the company is.
Score
TMC Life Sciences Bhd's solvency score is 65/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
TMCLIFE Price Targets Summary
TMC Life Sciences Bhd
Shareholder Return
TMCLIFE Price
TMC Life Sciences Bhd
Average Annual Return | -2.4% |
Standard Deviation of Annual Returns | 18.82% |
Max Drawdown | -91% |
Market Capitalization | 1.2B MYR |
Shares Outstanding | 1 741 882 400 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
TMC Life Sciences Bhd.operates as an investment holding company. The company is headquartered in Petaling Jaya, Selangor and currently employs 1,108 full-time employees. The company went IPO on 2005-10-06. The firm's subsidiaries include IVF Technologies Sdn. Bhd., which is a provision of fertility services and operation of women’s clinic; TMC Biotech Sdn. Bhd., which is a provision of fertility consultancy, laboratory and embryology services and research and development; TMC Lifestyle Sdn. Bhd., which is developing, marketing and management of healthcare programs; TMC Properties Sdn. Bhd., which is a property investment; Thomson TCM Sdn. Bhd., which is a provides traditional and complementary services; BB Waterfront Sdn. Bhd., which provides healthcare services, TMC Women’s Specialist Holdings Sdn. Bhd., which is in the business of operating fertility centers and providing related services, and TMC Care Sdn. Bhd., which is engaged in the provision of pharmacy services and products, and management support services.
Contact
IPO
Employees
Officers
The intrinsic value of one TMCLIFE stock under the Base Case scenario is 0.694 MYR.
Compared to the current market price of 0.665 MYR, TMC Life Sciences Bhd is Undervalued by 4%.